INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

21,638 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
DD
Dockery Derrick D.Director
TLSTELOS CORP
Open-market sale
SELL$17K
4,100 sh
Mar 19, 2026Mar 20, 2026
Page 359 of 541
← PrevNext →
traded Mar 19, 2026
+1d
SEC Form 4

Evidence

26
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
5,044 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

25
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Open-market purchase
BUY$14K
500 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

25
SS
Shah Aarti S.Director
NVDANVIDIA CORP
Open-market sale · 10b5-1 plan
SELL$36K
202 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

25
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Open-market purchase
BUY$14K
500 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

25
MT
McMillen Charles ThomasDirector
CTMCastellum, Inc.
Open-market sale
SELL$44K
55.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

24
CJ
Caljouw Lynne JEVP, Chief HR Officer
STSensata Technologies Holding plc
Open-market sale
SELL$86K
2,480 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

24
PC
Popeck Thomas CCEO, Henry Schein Products
HSICHENRY SCHEIN INC
Open-market sale
SELL$99K
1,355 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

23
MM
Moore MichaelPresident
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$371K
40.2K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

23
MM
Moore MichaelPresident
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$570K
65.0K sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

23
MA
Madan Gopal AjayChief Financial Officer
REALTheRealReal, Inc.
Open-market sale
SELL$479K
51.6K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

22
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$297K
6,161 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

20
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,913
608 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
VC
Van Tuyl ChristopherChief Legal Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$72K
2,877 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

20
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,486 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,274
684 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$88K
34.4K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

20
TP
Toth PeterEVP, Chief Sustain & Dev Off
NEMNEWMONT Corp /DE/
Open-market sale · 10b5-1 plan
SELL$324K
3,000 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

20
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,907
608 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$5,671
1,183 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,705
774 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

20
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$1,818
380 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

19
TD
Travers DavidPresident and interim CFO
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$60K
23.7K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

19
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$187K
3,795 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

17
HJ
Hogan Michael JamesChief Business Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$78K
1,800 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

16
ST
Sakamoto Ryan T.EVP, Chief Legal Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$6,399
2,495 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

16
GA
Garefis AmyEVP, Chief People Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$6,492
2,532 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

15
RR
Reich RichardSVP and Gen Counsel
NJRNEW JERSEY RESOURCES CORP
Open-market sale · 10b5-1 plan
SELL$289K
5,449 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

15
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$1.03M
25.6K sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

13
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$687K
16.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

13
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$23K
9,722 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

13
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$21K
9,722 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

13
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$448K
10.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

12
HB
Herraiz Lizette BenediGENERAL COUNSEL
STRAStrategic Education, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
2,982 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

11
DD
Dieter DavidEVP & General Counsel
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL$488K
14.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$165K
9,742 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

5
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$180K
4,352 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

1
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$106K
2,481 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC Form 4

Evidence

57
MV
Maphai Thabane VincentDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$160K
12.0K sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

54
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$26.94M
1.79M sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K